IDSA FOUNDATION NEWSLETTER
Our Monthly Newsletter provides highlights from our top news and information regarding latest initiatives.
Celebrating Hispanic Heritage Month
SEPT. 15 - OCT. 15
Inclusion, diversity, equity and access stand at the center of the IDSA Foundation’s mission to reduce the burdens of infectious diseases worldwide. Diversity drives creativity and innovation, both key components of scientific exploration and equitable patient care.
We are proud to celebrate Hispanic Heritage Month to honor all of the physicians, researchers and health care professionals whose contributions to medicine furthered the development of novel treatments and led to groundbreaking discoveries. Help us amplify the successes of the Hispanic health care community by saluting your peers on social media and marking your calendars for our upcoming Hispanic Heritage Month virtual event.
Thanks to You, We Met Our Match!
We did it! Together we surpassed our goal and raised $50,000 during our Summer of Science campaign to support life-saving research and fund the ID workforce of tomorrow. Our generous donors and corporate sponsors make it possible for us to continue our work to equip the ID community with the tools needed to combat the next infectious diseases threat. Thank you to all of you who celebrated a Summer of Science with us!
Honoring the 2021 Women of ID
The IDSA Foundation is proud to honor Liise-anne Pirofski, MD, FACP, FIDSA, as a 2021 Women of ID honoree. From studying art history to tackling antibody immunity, the path Dr. Pirofski took to get where she is today in the field of infectious diseases is anything but typical. However, one thing has remained constant throughout her career: her drive to make the world a better place and help others. Read more about her journey in ID, her passion for mentorship and what she hopes to see for the future of the field.
New this year, there is up to $1.7 million in total grant funding available to researchers of all levels — including early-career investigators — and across all disciplines. Watch this year’s informational webinar and visit idsafoundation.org/alz-research-grant/ to learn more.
IDSA Foundation/HIVMA Clinical Fellowship Program now open
HIVMA and the IDSA Foundation are pleased to announce the 2022-2023 HIV Clinical Fellowship Program call for applications. This fellowship program supports physicians who are not yet trained in infectious diseases in pursuing one year of HIV clinical training under the mentorship of an HIVMA member at clinical sites serving medically underserved populations. The award includes a stipend and funds to cover the fringe benefits provided by the sponsoring organization and an additional $5,000 to support educational opportunities or offset administrative costs. Applications close Nov. 8.
2021 IDea Incubator
Watch top finalists pitch their innovations that have the potential to improve ID care at the IDSA Foundation’s 2021 IDea Incubator in collaboration with Johnson and Johnson Innovation – JLABS (‘JLABS’) live at IDWeek on Tuesday, Sept. 28, from 5 p.m. to 6 p.m. ET. Register to attend today!
Are you caught up on the IDSA Foundation’s latest blogs? We are committed to sharing insights from ID specialists across the country and providing the latest IDSA Foundation news.
Vaccines 101: Celebrating Science’s Greatest Superpower: As we celebrate the life-saving superpowers of science, we decided to reflect on the history of vaccines, dive deeper into how they work and offer insight into why they’re one of the most important tools we have in the fight against infectious diseases – including COVID-19. Read more.
Industry Partner Spotlight: Gilead Sciences
The IDSA Foundation’s Industry Partners ensure our work continues for years to come. Thanks to our generous supporters, we can support life-saving research, fund innovative programs and cultivate the next generation of diverse infectious diseases professionals. We’re proud to highlight our Industry Partners to showcase what they do best. This month, we’re putting the spotlight on Gilead Sciences:
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. Learn more at www.gilead.com.